市场调查报告书
商品编码
1466334
生医材料市场:按类型、分类和应用 - 2024-2030 年全球预测Biomaterials Market by Type (Ceramics, Metallic Biomaterials, Natural Biomaterials), Classification (Bioactive Biomaterials, Bioinert Biomaterials, Bioresorbable Biomaterials), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年生医材料市场规模为1,672.8亿美元,预估2024年将达1,933.8亿美元,2030年将达4,641.8亿美元,复合年增长率为15.69%。
生医材料市场包括出于医疗原因(例如诊断、治疗和替代操作)与生物系统相互作用的天然或合成材料的开发、生产和行销。世界人口老化以及随之而来的慢性病和文明病的增加是市场的主要需求驱动力。此外,医疗植入的日益采用和整容手术数量的增加也促进了市场的成长。开发更复杂和改进的生医材料的技术进步进一步刺激了市场扩张。此外,医疗保健支出的增加、奈米技术和再生医学的进步正在推动生医材料市场的发展。然而,新生医材料的核准有严格的监管要求,由于核准过程耗时且成本高昂,这可能会限制市场成长。此外,生物相容性问题和体内副作用的发生也可能对市场成长构成挑战。此外,能够响应生物刺激的智慧生医材料的开拓以及生医材料与活细胞和组织的整合以创建更复杂的组织结构预计将为马苏创造新的市场成长机会。此外,3D列印技术的创新和个人化医疗领域的成长预计也将为业务成长提供重大机会。
主要市场统计 | |
---|---|
基准年[2023] | 1672.8亿美元 |
预测年份 [2024] | 1933.8亿美元 |
预测年份 [2030] | 4641.8亿美元 |
复合年增长率(%) | 15.69% |
类型: 天然材料的进步以提高功能性生医材料
陶瓷因其生物相容性、卓越的强度和硬度而常用于整形外科和牙科应用。陶瓷包括氧化锆等惰性材料和羟磷石灰等生物活性材料。陶瓷因其在承载应用中的稳定性和耐用性而通常受到青睐。金属生医材料以其高机械强度而着称,主要用于整形外科和心血管应用。天然生医材料源自生物体,因其优异的生物相容性和功能性而被选择。胶原蛋白、甲壳质、海藻酸和丝等天然生医材料广泛用于组织工程和创伤治疗应用。聚合生医材料,包括天然和合成聚合物,是用于各种医疗设备和植入的通用材料。
应用:生医材料在工业中的多种应用
生医材料在心血管领域的应用主要集中在人造血管、心臟瓣膜和支架的建构。这项需求源于全球心血管疾病 (CVD) 盛行率的不断上升,推动了对耐用、生物相容性材料的需求。在牙科领域,生医材料用于填充物、植入和重组手术。对美容牙科的日益重视和牙科疾病发病率的增加正在推动对生医材料的需求。神经系统生医材料用于治疗神经损伤、脑肿瘤和神经退化性疾病。对生医材料的需求是由神经组织的复杂性以及对模拟或支持神经功能的材料的需求所驱动的。在眼科领域,生医材料用于隐形眼镜、人工水晶体(IOL) 和角膜植入。生医材料的整形外科应用包括关节重建、骨移植和骨再生支架,解决肌肉骨骼疾病和运动伤害日益增长的趋势。整形外科中的生医材料用于软组织填充材、植入和重组支架。组织工程应用利用生医材料来开发人造器官和再生解决方案。创伤治疗中的生医材料可应用于敷料、缝线和皮肤移植。这种需求源自于对更快癒合、降低感染率和改善慢性伤口管理结果的追求。
区域洞察
以美国和加拿大为中心的美洲地区对高端医疗设备和植入中的合成生医材料表现出浓厚的兴趣。美国市场由创新产品开发和广泛的研究资金推动,包括对医疗应用 3D 列印技术的大量投资。在政府致力于永续医疗保健解决方案的支持下,加拿大对生物聚合物的兴趣日益浓厚。欧洲、中东和非洲(Europe、Middle East and Africa)呈现出受监管、经济和人口因素影响的多样化客户需求。欧洲国家因其强大的法规结构而脱颖而出,支持生医材料的高品质标准和永续性,并在奈米技术和生物可吸收材料方面进行了大量研究。中东医疗基础设施快速发展,为尖端医疗设备和植入提供了商机。非洲正处于市场开拓的早期阶段,但在不断增长的医疗投资和意识的推动下,它显示了天然和永续生医材料的潜力。在包括中国、日本和印度在内的亚太地区,由于人口老化和医疗基础设施投资增加,对生医材料的需求正在迅速增长。作为一个规模和成长率都领先的市场,中国是技术创新的中心,一系列生物分解性材料和回收产品的新专利就证明了这一点。日本正专注于医疗应用聚合物和复合材料的前沿研究。随着製药和医疗领域的强劲成长,印度对天然材料的需求很高。
FPNV定位矩阵
FPNV定位矩阵对于评估生医材料市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生医材料市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动以及突破性产品开发的见解。
1.生医材料市场的市场规模与预测是多少?
2.在生医材料市场预测期内,我们应该考虑投资哪些产品与应用?
3.生医材料市场的技术趋势和法规结构是什么?
4.生医材料市场主要厂商的市场占有率为何?
5. 进入生医材料市场的适当型态和策略手段是什么?
[192 Pages Report] The Biomaterials Market size was estimated at USD 167.28 billion in 2023 and expected to reach USD 193.38 billion in 2024, at a CAGR 15.69% to reach USD 464.18 billion by 2030.
The biomaterials market includes developing, producing, and marketing natural or synthetic materials that interact with biological systems for medical reasons, such as diagnostic, therapeutic, or replacement operations. An aging global population and the resulting increase in occurrences of chronic and lifestyle diseases are major demand drivers for the market. The rise in the adoption of medical implants and an upswing in the number of cosmetic and plastic surgeries also contribute to market growth. Technological advancements for the development of more sophisticated and improved biomaterials are further stimulating market expansion. Moreover, increased healthcare expenditure and advancements in nanotechnology and regenerative medicine are buoying the biomaterials market. However, strict regulatory requirements for the approval of new biomaterials can lead to lengthy and expensive approval processes, limiting the market growth. Biocompatibility issues and incidences of adverse reactions within the body may also challenge the market growth. Moreover, the development of smart biomaterials that can respond to biological stimuli and the integration of biomaterials with living cells and tissues to produce more complex tissue constructs are expected to create new opportunities for market growth. Innovations in 3D printing technologies and the growing field of personalized medicine are also anticipated to present significant opportunities for business growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 167.28 billion |
Estimated Year [2024] | USD 193.38 billion |
Forecast Year [2030] | USD 464.18 billion |
CAGR (%) | 15.69% |
Type:Advancements in Natural biomaterials for improved functionality
Ceramics are favored for their biocompatibility, exceptional strength, and hardness, as they are commonly used in orthopedic and dental applications. Ceramics include bioinert materials such as zirconia and bioactive materials such as hydroxyapatite. The preference for ceramics is often due to their stability and durability in load-bearing applications. Metallic biomaterials stand out for their high mechanical strength and are predominantly used in orthopedic and cardiovascular applications. Natural biomaterials are derived from living organisms and are selected for their excellent biocompatibility and functionality. Natural biomaterials, including collagen, chitin, alginate, and silk, are extensively used in tissue engineering and wound healing applications. Polymeric biomaterials, including natural and synthetic polymers, are versatile materials used in various medical devices and implants.
Application: Diverse applications of biomaterials across industries
In cardiovascular applications, biomaterials primarily focus on constructing blood vessel prostheses, heart valves, and stents. The need arises from the increasing prevalence of cardiovascular diseases (CVDs) globally, driving demand for durable and biocompatible materials. The dental segment utilizes biomaterials for fillings, implants, and reconstructive surgery. The growing emphasis on aesthetic dentistry and the increasing incidence of dental diseases drive the demand for biomaterials. Biomaterials for the nervous system are utilized in treatments for neural injuries, brain tumors, and neurodegenerative diseases. The demand for biomaterials is propelled by the complexity of neural tissues and the need for materials that mimic or support neural function. In ophthalmology, biomaterials find applications in contact lenses, intraocular lenses (IOLs), and corneal implants, driven by the rising prevalence of visual impairments and a desire for minimally invasive solutions. Orthopedic applications of biomaterials include joint replacements, bone grafts, and scaffolds for bone regeneration, targeting the increasing incidence of musculoskeletal conditions and sports injuries. Biomaterials in plastic surgery are used for soft tissue fillers, implants, and reconstructive scaffolds. Tissue engineering applications harness biomaterials to develop artificial organs and regenerative solutions. Biomaterials in wound healing are applied in dressings, sutures, and skin grafts. The need stems from the quest for faster healing, reduced infection rates, and improved outcomes in chronic wound management.
Regional Insights
The Americas region, primarily the United States and Canada, demonstrates a substantial interest in synthetic biomaterials in high-end medical devices and implants. The U.S. market is driven by innovative product development and extensive research funding, including significant investments in 3D printing technologies for medical applications. Canada showcases a growing interest in biopolymers, supported by government initiatives towards sustainable healthcare solutions. Europe, the Middle East, and Africa (EMEA) exhibit diverse customer needs influenced by regulatory, economic, and demographic factors. European countries stand out for their stringent regulatory frameworks favoring high-quality standards and sustainability in biomaterials, with notable research in nanotechnology and bioresorbable materials. The Middle East, with its rapidly developing healthcare infrastructure, presents opportunities for advanced medical devices and implants. Africa, although in the early stages of market development, shows potential for natural and sustainable biomaterials driven by increasing healthcare investments and awareness. The Asia Pacific region, consisting of China, Japan, India, and other countries, is witnessing a surge in demand for biomaterials due to a growing aging population and increased healthcare infrastructure investments. China, leading in both market size and growth, is a hub for innovation, evident from its series of new patents in biodegradable materials and regenerative products. Japan focuses on advanced research in polymers and composites for healthcare applications. India, with a robust growth in pharmaceutical and healthcare sectors, shows a high demand for natural biomaterials.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biomaterials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomaterials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Ametex Inc., BASF SE, Berkeley Advanced Biomaterials, Braskem, CAM Bioceramics B.V., CDI Products, Celanese Corporation, CeramTec GmbH, CoorsTek, Inc., Corbion NV, Covalon Technologies Ltd., Danimer Scientific, Dentsply Sirona Inc., Eastman Chemical Company, Evonik Industries AG, GELITA AG, Invibio Ltd. by Victrex PLC, Koninklijke DSM N.V., KURARAY Co., Ltd., Medical Device Business Services, Inc. by Johnson & Johnson Services, Inc., Medtronic Plc, Noble Biomaterials, Stryker Corporation, Tissium, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biomaterials Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomaterials Market?
3. What are the technology trends and regulatory frameworks in the Biomaterials Market?
4. What is the market share of the leading vendors in the Biomaterials Market?
5. Which modes and strategic moves are suitable for entering the Biomaterials Market?